Adeyomoye Olorunsola Israel, Adetunji Juliana Bunmi, Olaniyan Olugbemi Temitope, Adetunji Charles Oluwaseun, Ogunmiluyi Oluwafunmbi Ebenezer, Uwejigho Raphael Eguono
Department of Physiology, University of Medical Sciences, Ondo City, Nigeria.
Department of Biochemistry, Osun State University, Osogbo, Nigeria.
Toxicol Rep. 2025 Apr 18;14:102028. doi: 10.1016/j.toxrep.2025.102028. eCollection 2025 Jun.
Cardiovascular complications are a significant concern in diabetes mellitus. Vahl leaf has been traditionally used for diabetes management, yet its impact on cardiovascular biomarkers in diabetic conditions remains unexplored. This study evaluated the effects of methanol extract of (MEFE) on antioxidant defense, oxidative stress markers, ion transport enzymes, inflammatory mediators, and cardiovascular gene expression in diabetic Wistar rats. Twenty Wistar rats were divided into four groups (n = 5): control, diabetic untreated, diabetes + MEFE (200 mg/kg), and diabetes + insulin (0.3 IU). Diabetes was induced with alloxan monohydrate (150 mg/kg), and treatments were administered orally for 28 days. Antioxidant enzyme activities (Glutathione peroxidase (GPx), Glutathione reductase (GR), Superoxide dismutase (SOD), Catalase, malondialdehyde and 8-hydroxy-2'-deoxyguanosine), Cardiac biomarkers (Na/K ATPase, Ca ATPase, Creatinine kinase-myocardial band (CK-MB), Troponin I, Troponin T, and Lactatate dehydrogenase), and gene expression of CRP, ACE, P-Selectin, and eNOS were evaluated. Data were analyzed using one-way analysis of variance, expressed as mean ± SEM, and p < 0.05 was considered statistically significant. The diabetic group treated with MEFE (200 mg/kg) significantly increased Ca²⁺ ATPase, SOD, and glutathione reductase activities compared to diabetic untreated. However, malondialdehyde and 8-OHdG levels decreased significantly in diabetes+MEFE (200 mg/kg) compared to diabetes untreated. CK-MB levels increased significantly in diabetes+MEFE (200 mg/kg) compared to diabetic untreated. MEFE reduced ACE and P-selectin expression in diabetes+MEFE (200 mg/kg) compared to diabetic untreated, indicating potential antihypertensive and anti-thrombotic effects. However, it increased CRP levels compared to control, suggesting an inflammatory response. MEFE significantly reduced eNOS expression compared to diabetic untreated, suggesting impaired vascular function. These findings suggest that while has some beneficial effects, its impact on inflammatory and cardiac biomarkers necessitates further research to fully understand its therapeutic potential and safety.
心血管并发症是糖尿病患者的一个重大问题。传统上,瓦勒叶被用于糖尿病管理,但其对糖尿病状态下心血管生物标志物的影响仍未得到探索。本研究评估了瓦勒叶甲醇提取物(MEFE)对糖尿病Wistar大鼠抗氧化防御、氧化应激标志物、离子转运酶、炎症介质和心血管基因表达的影响。将20只Wistar大鼠分为四组(n = 5):对照组、未治疗糖尿病组、糖尿病 + MEFE(200 mg/kg)组和糖尿病 + 胰岛素(0.3 IU)组。用一水合四氧嘧啶(150 mg/kg)诱导糖尿病,口服给药28天。评估抗氧化酶活性(谷胱甘肽过氧化物酶(GPx)、谷胱甘肽还原酶(GR)、超氧化物歧化酶(SOD)、过氧化氢酶、丙二醛和8-羟基-2'-脱氧鸟苷)、心脏生物标志物(钠钾ATP酶、钙ATP酶、肌酸激酶心肌带(CK-MB)、肌钙蛋白I、肌钙蛋白T和乳酸脱氢酶)以及C反应蛋白、血管紧张素转换酶、P-选择素和内皮型一氧化氮合酶的基因表达。数据采用单因素方差分析进行分析,以均值 ± 标准误表示,p < 0.05被认为具有统计学意义。与未治疗糖尿病组相比,用MEFE(200 mg/kg)治疗的糖尿病组显著提高了钙ATP酶、SOD和谷胱甘肽还原酶的活性。然而,与未治疗糖尿病组相比,糖尿病 + MEFE(200 mg/kg)组的丙二醛和8-OHdG水平显著降低。与未治疗糖尿病组相比,糖尿病 + MEFE(200 mg/kg)组的CK-MB水平显著升高。与未治疗糖尿病组相比,MEFE降低了糖尿病 + MEFE(200 mg/kg)组中血管紧张素转换酶和P-选择素的表达,表明其具有潜在的降压和抗血栓作用。然而,与对照组相比,它增加了C反应蛋白水平,提示有炎症反应。与未治疗糖尿病组相比,MEFE显著降低了内皮型一氧化氮合酶的表达,提示血管功能受损。这些发现表明,虽然瓦勒叶有一些有益作用,但其对炎症和心脏生物标志物的影响需要进一步研究,以充分了解其治疗潜力和安全性。